Skip to main content

Idex Corp Investor Event Transcript, Nov 16, 2026

Idex Corp (IEX)

IDEX said data centers, semiconductor and space and defense grew close to 50% year to date; mid single digit plus organic growth and mid to high 30s flow through support double digits EPS, with a $75 million a quarter repurchase run rate. AI summary

Investor Event Transcript 2026-11-16 For: 2026-12-31
Added on November 16, 2026

Conference Transcript - IEX 2026-11-16

Operator

Good afternoon. Please welcome from IDEX Corporation, Chief Executive Officer Eric Ashelman and Chief Financial Officer Sean Gillen, alongside Research Analyst of RBC Capital Markets, Jeff Reeve. Good afternoon. Please welcome Chief Executive Officer of Carmen Space and Defense. Please welcome, from IDEX Corporation, Chief Executive Officer Eric Ashelman and Chief Financial Officer Sean Gillen, alongside Research Analyst of RBC Capital Markets, Jeff Reeve.

Jeff Reeve, Analyst — RBC Capital Markets

Good afternoon, everyone. Good afternoon, everyone, and welcome. I hope you're enjoying the conference so far. For those of you who I haven't had the opportunity to meet, I'm Jeffrey, and I cover the multi-industry and electrical equipment sector here at RBC. Before we get started, I want to thank everyone for joining us today and give a special thanks to our RBC conference and corporate access teams for all the work that goes into putting together an event like this. We're very pleased to have IDEX Corporation joining us for today's keynote lunch. With us today are Eric Ashleman, President and CEO, and Sean Gillen, CFO. We'll start with a brief presentation for management and then spend the balance of our time discussing IDEX's growth strategy, operating outlook, and capital allocation. With that, Eric, I'll pass it over to you.

Eric D. Ashleman, CEO

Okay. Well, thanks. Great to be here with everybody, and I appreciate to have the opportunity to entertain you during lunch. So what I'm going to do is just cover some fundamental facts about IDEX. You know, IDEX over time, take you through some of the evolution. We'll spend some time talking about the markets that are growing really, really nicely for us, most all of which were more recently acquired. I'll pass it over to Sean to talk a little bit about capital deployment. We'll bring it home and then reference all of it through Q&A. So it's an interesting company, if you're not super familiar with it. You know, we went public in the late 80s, and we've had these three phases of distinct evolution along the way. Honestly, for the first 20 years, it was a kind of a loosely held holding company, and there wasn't a lot of things done across the businesses, but some great foundational firms. Base two, I joined a little ahead of this in 2008. We had this great run for about 10 years where we did two things really, really well. We took these incredible businesses and lifted them from kind of medium performance to full potential on the backs of two pieces of work. One, we spent a lot of time growing our own leaders within the company. Running an IDEX-like business is not for everyone. There's some special skills of how you do that. They're very technology forward. And so we kind of flipped the ratio, went from three out of four senior managers being brought in from the outside to a very quick move to have that ratio go the other way. We've held that for now 20 years. So we did that and then extended the capacity of those leaders when we brought 80-20 to IDEX. And I know you see it around a lot more today than you used to, but we've been on the 80-20 journey for over 15 years. So those two things together really accounted for some incredible run in that 10-year period. Almost all of it realized through margin appreciation. So a lot of internal optimization, really fine-tuning businesses. To be candid, the growth side of it actually was probably underrepresented because we actually intentionally took a lot of revenue off the board to tune the businesses in the way that we did. Now, as we were entering that second phase, I could kind of see, hey, at some point, we're going to have a kind of a capping issue here. We're going to run into our own contribution margin. And in fact, we've now built so many capabilities and such a strong balance sheet, it's time to extend this into another place. And then a lot of that's in the phase three that we're talking about here. Essentially, if we want to drive the same double digits expansion and compound that on a routine and annual basis, we're going to need to get more of it out of the top of the P&L than just simply the optimization on the middle portions there. And so what we did is we did a ton of research. Coincidentally, while we were all locked in our houses in the pandemic, we ripped apart a bunch of verticals, looked at different technologies, things that would complement and, frankly, upgrade IDEX. And so we did a burst of acquisitions over about a five-year period, 11 businesses brought into IDEX, four we actually divested on the way out, so a net gain of seven, and really changed fundamentally our HST segment, which is where I think we'll spend a lot of time today. And they're very similar to traditional IDEX businesses, but they bring these technologies that are uniquely aligned around a lot of things that we're seeing form around us today. And frankly, for us, it's driving a lot of the growth of the company. So I talked about some things that have changed, and we'll go reference where we are today. Some things, though, are amazingly consistent and have not changed at all. So we have a distinct filter that we use to sort of gauge an IDEX business and whether Whether or not it's a good one, either because we own it or we are interested in acquiring it, we like components. We like kind of coming to market with things that, honestly, you can hold in your hand and pick up because they have the potential to deliver a ton of criticality at a relatively low price point, and they're buried deep within a very sophisticated bill of materials. That explains a bunch of the economic engines and attributes that we have in the company. It's why we get pricing power. It's why we get stickiness that grows and sort of serves as an annuity stream over time. And so that was true years ago. It's still true today. We really haven't changed it. We have very few exceptions to that. In a moment, I'm going to talk about how that leverages into something I call tunability. But for now, you can recognize that that was long here and is here today. It's really, really asset light. So CapEx is a percentage of revenue Revenue for us is single digits. And we took our number up this year for the first time ever. I've worked here almost 20 years and have never seen it. And even there, I think we moved from $90 million to $110 million. So we're able to capitalize a lot of revenue relatively modestly, whether it's new markets or others. What that does is, again, gives us a lot of agility. It gives us great cash generation, too. Essentially, we're going to market engineer to engineer. Usually, that's the launch point into a business with a customer. That's where we build advocacy, kind of defends us, helps extend that moat, frankly, defends us against the purchasing side of the house. Again, that helps us lever the economics. Today, these are the businesses that are driving a lot of the growth for IDEX. You know, we kind of just started to see movement here in about the second half of 25. It's inflected a lot here in 26, and it's been nice and steady every quarter along the way, kind of fundamentally changed the nature of our order book. And so essentially, you see four verticals that are represented here together all in with water included, which is an FMT business. This covers just under 30% of IDEX. But again, it's driving a disproportionate part of the growth. And all that recent acquisition I talked to you about, this is where those businesses are. This is where they sit. So just to give you a little bit of highlights, we'll probably come back on some of this from a data center perspective. Like a lot of companies, we have a bit of presence here. We had zero incumbency in this world, and we didn't have a lot of ready-made stuff on the shelf when this revolution took off to just go grab. What we've done is we've found these entry points where kind of the incumbency doesn't work right, and then the problem needs to get fixed. We come in engineer to engineer. We iterate in fast iteration, and then we find an answer. Once we cement it there, we get the uptick. So as the market grows, we grow with it. We also get an opportunity to go look for other things to fix. So we have kind of three applications that we can come back to later that go to work in data centers. Semiconductor, we've always had a presence here. We try to keep it kind of capped at a reasonable level, about 10 percent-ish, maybe a little higher on some years, just because of the inherent cyclicality of it. But essentially, all the work we're doing is either in, it's all involved around wafer fabrication. We're either in deep in the lithography instrumentation, often on the severe duty side, really tough applications, or metrology. So a bunch of our optics businesses are validating the chips that you manufacture. About half of what we do there is consumables, so filtration, seals on doors and things. So as long as you're running the system, we get some recurrence there. The other half are very, very critical technologies, often not known unless you're really a specialized engineer. Space and defense is an area I'm super excited about. Primarily, we're involved with low-Earth orbit optics, and so we've kind of been with this industry from the early days. And over time, we've acquired businesses where essentially the job we do is we help the constellations talk to each other, the satellites that are up there. We're shooting lasers, we're catching lasers, filtering out ambient light, and we've become kind of the de facto standard of how that's done, how that works. And then obviously, as that's kind of going right and left, and other people and other companies come into the mix, often what happens is something critical that's been already defined, it's kind of flavors on a theme, and we become sort of ubiquitously known as somebody who does the work. So some great things going on there. And then finally, water, which is in our FMT segment. This is actually analytics for the product. It's a more software-intensive business. We have sewer robo-crawlers and flow meterings, but then we take all those data signals and we actually interpret them. And for a municipality, we tell them why their system either works or doesn't. If they want to spend CapEx on it, that's kind of their choice. We're somewhat agnostic to that, but we essentially interpret the system for them. So we can come back again, but a lot of growth coming out of these areas, and it's great to see the capital being put to work and coming to fruition this way. I want to just touch a little bit on something that's often under, I guess, underappreciated, if you will, is the inherent tunability that comes with component orientation. And so I think in the setup slide here that the RBC folks put in, you heard some folks talking about disruption and lack of predictability. And, you know, probably ever since the pandemic, we sort of assume we're going to go through things where every year there's going to be something that's unanticipated that it takes markets left and right in a way that nobody can see coming. Well, this is where we look back and said, you know, our component orientation actually allows it in line with 80-20 for us to move really fast left and right and deal with that and not get rocked by it. So I've got three examples here that we referenced on our last earning calls, where you can see in a couple of them, we had some medical market applications. And as you know, that market had some de-stocking issues here post-pandemic. So as those sort of ebbed a little bit to the downside, we were able to take the exact same technology, the same people in the same buildings most times, and marshal it over to more advanced, faster-growing applications. And because of our culture and topography, we have super flat organizational structures. Sean and I don't babysit a lot of this. Those decisions can be made. We have a lot of a decision-making autonomy. They can make those decisions really fast. And so we saw some of this play out. We can talk about other examples. But essentially, this is kind of how the system works and I think allows us to say at any one time, something could go right or left. But if it does, we're not. Drowning in capitalization, we can make this move quickly and we can go react to it within business-to-business or across business boundaries. And I'll just have Sean, you cover a little bit on the capital deployment side.

Sean M. Gillen, CFO

Yep. I'll touch on just the balance sheet and capital deployment broadly. So your headline is balance sheet is in really good shape. You can see the leverage has come down a little bit over the past year. And frankly, that's all from EBITDA growth, right? There's not a lot of debt pay down. So balance sheet's in good shape in terms of capital deployment so far in this year. We have stepped up the CapEx investments in the business to help support some of the growth that we're not only seeing today, but the growth that we see over the next few years. And so it's still pretty capital light. You can see last year, year to date, was 44 million of CapEx. We've stepped that up to 66. We do expect for the full year to be around 110 in CapEx. M&A, we have a pipeline that we're working, and we do see opportunity, but year-to-date have not completed an acquisition, and that leaves the balance of the capital deployment towards capital return. So steady dividends, to increase that with earnings each year, and then the share repurchase is the lever that we have flexibility on, depending on how M&A comes to fruition. So we stepped up share repurchase activity going back a little over a year now. So the run rate today is about $75 million a quarter. And that's probably the base case for the time being. If M&A, if we start to have a deal or two convert, we could pull back on share repurchase. And if we don't have a deal or two come into focus, we can step that up. And then the framework is on the right. So number one, of course, is to maintain the flexible balance sheet, maintain investment credit ratings. We're clearly well in the zone of that. We'll look to continue to invest and support the growth in our business. Again, there's not a lot of capital to do that, but we do want to make sure we're supporting the business with growth. And then I've touched on M&A and capital return and the interplay of those two. So that's a little bit on the numbers year to date and then some methodology as we think about allocating capital across the company.

Eric D. Ashleman, CEO

Okay, so we'll turn it over to you, and maybe I'll just keep some of the markets up here because I know we'll go over those.

Jeff Reeve, Analyst — RBC Capital Markets

Yeah, great. So, Eric, you highlighted the four advantage markets where IDEX is targeting higher growth. Can you help us size these opportunities? How should investors think about IDEX's potential for that exposure to grow over the next, say, three to five years?

Eric D. Ashleman, CEO

Yeah, well, again, it's kind of leading the way for us now with essentially what we tried to build here is an HST segment that would lead the way for growth in IDEX. You know, generally over a cycle had it, I think, dialed into somewhere around high single digits or through time. It's actually above that now. So that's kind of its mission for the company, if you will. And the markets that at least the first three here, those are the HST areas, and they're driving a lot of that growth today just because there's such fundamentally strong businesses. So I think what we have up here, we probably take our life sciences businesses and put it here from a potential perspective. You know, that's now just starting to kind of come out of that post-pandemic swoon, if you will. It's returning to growth, and there's some things that we're very interested there. So probably these four plus life sciences, I think, will carry a lot of the growth velocity for the company, certainly the piece that's above average as we go forward. Durability, I'd say in every one of these spaces, you know, we've got some initial nascent positions, and as we get deeper and deeper, there's only, honestly, a handful of customers that are sort of blazing the trails in at least the HST-centric pieces. We've got... We've got a depth with them that probably punches above our weight because of the criticality that we have, and as we've assembled more mass and are starting to integrate it and work the pieces a little bit together in ways that are not typical for us, that in itself is opening up a lot of doorways where our engineers can begin to go in and tinker and work on the next solution.

Jeff Reeve, Analyst — RBC Capital Markets

Would it be possible to get some numbers behind these growth rates for some of these markets? And then maybe if we could break it down further, just the opportunity, is it just the markets themselves growing? Is it increasing content, gaining share?

Sean M. Gillen, CFO

I'll give a little kind of context. We touched on some of this on the most recent earnings call. So in these kind of three advantage areas, the ones currently on the screen, so that's a little over a third of HST to dimensionalize, though. We've kind of talked about semiconductor. This is a portion of the HST segment. Semiconductor would be kind of in that 15% to 20% zip code for the segment. And then data center would be the second biggest in space and defense the next. I give you kind of a little bit of a rough magnitude of each of these. And those three areas of the company, we mentioned on the Q3 earnings call year-to-date, have been growing close to 50%. So a lot of the growth, of course, not only in HST, but for the whole company, is coming from those three areas. And within that, as you'd probably expect, data centers punching above that 50%, semiconductor probably kind of right on it, and then space and defense a little bit below. So I'll give you a little context and magnitude of each of these and then the relative growth rates.

Eric D. Ashleman, CEO

And while those fundamental market rates, if you will, are certainly attractive and we're positioned well to ride and rise as they do, every one of these three areas in particular have an awful lot of positions still to go explore and put down technical markers. You know, so if I look at the work we've done in space and defense, you know, we kind of started originally broadcasting via laser a signal to another satellite. We then acquired the business that had a lot of technology to catch it, and we jointly and through acquisition put a filter set around it so we'd be able to filter out ambient light. And so you kind of see there, you know, we have this one position, but it's sort of expanded threefold based on acquisition and organic development that we've done here to kind of own more of that work. Now we've expanded more recently into some things around ground installations, and that's sort of where it catches all of the things from space. So we kind of just keep walking down the food chain, if you will. So I'm as excited, if not more, based on how much room there is to travel in any one of these segments. The added bonus is it's in a space that's inherently growing really well underneath it.

Jeff Reeve, Analyst — RBC Capital Markets

When we think about sizing these opportunities, the bigger opportunity is expanding through new applications, or is it actually just getting better penetration of where you're already?

Eric D. Ashleman, CEO

I think over time, particularly medium-longer term, it's definitely more technology, more customers, more depth. Absolutely. Got it. That's the primary driver.

Jeff Reeve, Analyst — RBC Capital Markets

Yep. And so one concept you emphasized is the idea of tunability. So that's taking existing IDEX technology and applying it to new higher growth markets. How broadly applicable is that approach across the entire portfolio, and how meaningful can this be as a driver of organic growth?

Eric D. Ashleman, CEO

Well, it's a big deal, but I would say its primary use is within the actual business itself. We have some applications now we're starting to work across business boundaries, and that's generally a case of, you know, like in the case of the optics in space example that I walked through, There's something very distinct and different about catching a signal versus broadcasting it, but the two actually work in tandem, and owning them both allows you to tune both sides of it. So that's an example of cross-border work, but that's probably the exception more than the rule. The rule, I would use Mott as our best example. That's a big business for us. It was our largest acquisition. They had scaled to a point on their own that was pretty commendable, but what they were able to do is when we saw things like, When I first talked about that business years ago when we bought it, the number one market that we identified was energy. And it spanned all the way from classic filtration of fossil fuels all the way over to the hydrogen economy. As you might imagine along the way, that second piece of it, probably de-favored, de-emphasized a bit, certainly here in the U.S., is that has happened. We've essentially taken the exact same tech, much of the same capital, certainly the same resources, and that business has tuned a lot of it over to the growth in semi and semi-filtration. And so stepping back, what you're able to see is the growth rate of that business is better than it would have been before. And in their case, actually, the margin position is more advantaged as well on that side of the house. And so a lot of the growth and recovery that we've been talking about for that business, particularly on the margin side, based on the level it was when we bought it, it's being driven both from growth within the industries they're a part of, but this active tuning is giving it much more velocity. And I would say that kind of within a business, within the four walls, able to make those decisions the quickest, that's typically where it happens.

Jeff Reeve, Analyst — RBC Capital Markets

Are your business units incentivized to invest R&D dollars into expanding in the advantage markets?

Eric D. Ashleman, CEO

Well, they're certainly incentivized to grow and expand margins as they do it. And then they know, particularly the acquired businesses, we teach them 80-20. So we, you know, sometimes when they come in, particularly if they're founder-led, they were very often led the exact opposite, chase dollars, chase dollars, it's growth, it's growth, and it'll all work out in the end. We've, over the years, Come to see that what that actually does is dilute your resources and tends to inhibit growth in almost all of your vectors. And so instead, why don't you pick the two or three best ones that you have, disproportionately swing everybody over to them, and then we've long practiced individual incentive streams, even within businesses. So if we were to put, let's just pick, we'll stay on the space and defense, we have a team that that's all they do. Even though they're in a business that has a few other market access points, we are able to carve out their financials. They have their own mini P&L, and they're incentivized on growing it and growing it profitably. To the extent they all know, as all leaders in IDX do, if you tune things, you'll get there quicker, and we sanction that. That's absolutely part of that. Playbook.

Jeff Reeve, Analyst — RBC Capital Markets

Is it fair to say that kind of on these two new products, just given the limited incremental capital required, that they generate structurally higher ROIC?

Eric D. Ashleman, CEO

Well, they certainly, when they, I'll tell you this, when they work out, they're off the charts, because you're right, you're generally not introducing a whole new stream of bespoke capital that would then delay that return. You're often running it on the exact same equipment. So the CapEx, when we took that number up, a lot of it is actually for the space markets, a lot of it for kind of things that are going to happen around, you know, probably 28 and longer, because essentially of lift capacity is inflecting. But that equipment that's part of that, we run almost everything we make in that area through the same equipment. And so any deviation or timing difference there, it's not equipment that can only serve that one particular application. And that's pretty typical for most of the things we do.

Jeff Reeve, Analyst — RBC Capital Markets

Have there been any organizational capabilities you needed to build to identify and commercialize these opportunities more systematically?

Eric D. Ashleman, CEO

Well, because in some of these areas, semiconductor is a good one. There's only so many names, and when we get to a certain level, we saw this in health sciences or life sciences years ago. They don't want to deal with seven versions of us talking and having invoices flying all over the place. So one of the jobs we can do As we put a little bit of mass together, is particularly on the commercial side, present a more unified front. And where it makes sense. So we do a lot of that in all of these spaces. We're pretty efficient when we approach the major players in lithography or metrology. We represent now, here's all of the capabilities we have across IDEX. We streamline some of the back office processing and things you would have to do with a company like us. We do that as a benefit. You see the same thing in space and defense. You see it to a certain extent, maybe a little less so in data center because the solutions are very different. So whenever possible and it makes sense to a customer, we do it. If it doesn't, like as an administrative span break for us, we never do it. We want to see customer value. Otherwise, it just introduces more complexity in the business and we don't need that.

Jeff Reeve, Analyst — RBC Capital Markets

All right. I want to shift gears a little and talk about your health and science technology segment, just the recent strength in organic sales and order growth. So with three of your four advantage markets housed in this segment, how should investors think about the sustainability of that growth you've seen recently as the comps start to get more challenging?

Eric D. Ashleman, CEO

Well, a couple of things. So you're talking about HST, like the segment. Yeah. So obviously, here's a third of it that is being fired like crazy with these sort of markets coming on stream and acquisitions into them. So that's going to play a huge role. I think what's interesting, though, is let's talk about the other two-thirds. Well, one-third of the rest of HST is our life sciences businesses, which through their history have generally been mid-single digit to slightly better than that on kind of a continuous level. I think most of the industry was this way. The pandemic threw a wrench into the works because, you know, it was a cathartic health crisis. And as we saw in a bunch of other industries, you had sort of a stock up, stock up, and then recognition there's way too much inventory. You know, and it was clear that the severity of that was not as bad as people had anticipated. The other thing that made that drawdown side of that a little bit more pronounced was... You know, it was a big part of that world that had been built on the backs of kind of. Throwing technology into China. Post-COVID, that world was very, very different. So that had a kind of an add-on effect. I say all that because, you know, we stabilized a couple of years ago in that space. I mean, we reached sort of a trough sooner than a lot of others. We've seen it returning. We saw some of that in 25, 26. It's essentially the core fluidics markets are performing as we're used to seeing them. So I say all that because right now for IDEX, it's being counterbalanced on the negative side with kind of a big platform that we have that's sunsetting off. So we're sort of not booking a lot of growth in an area where the core franchise or the core markets actually are growing. So I say that to say that's opportunity for us because that third of HST should be on the board, will be on the board, and is really not there now. The other third of HST looks an awful lot like FMT. There's some more industrial-like applications in there. Those two, over the last few years, much of our broad industrial stuff has not had a lot of volume flex, as PMI levels have been generally under 50. Is that starting to lift? And we'll, I'm sure, talk about that and broaden. That actually impacts a third of HST, too. So I guess, you know, with an optimistic bent, you've got the segment performing kind of above our algorithmic levels that we set because of these markets, but you have two thirds of it that are in some ways artificially lower than they typically should be. I mean, we think down the road and long term would be strong contributors to the HST story as well.

Jeff Reeve, Analyst — RBC Capital Markets

So for the two-thirds of HST that, I guess, longer term you're excited about, when do you see that inflecting higher?

Eric D. Ashleman, CEO

Well, I think the sunsetting aspect of the life sciences market, again, that kind of rolls off as we exit the year here. So we'll be tied to more normative growth rates there. And then I'd say the industrial pieces, we could have the same discussion and call it FMT. It's broad enough. We've seen that get better throughout the year. You know, we kind of came into the year and assumed things were sort of flattish, and until it proved otherwise, we weren't going to call it. We got a little bit of movement, a lot of it being driven by the same secular forces we're seeing up here, data center more than anything else, in industrial applications. And so right about summertime, in back half, we've seen two other things enter the mix. Some really, really fatigued markets that we have and others have, ag and energy are the two for us. They actually inflected a bit off the bottom, so we see that as a positive sign going forward. Not back to old levels, but certainly coming off the map. And then maybe most importantly, we saw some broader lift in a number of businesses that we have that serve as industrial diagnostics companies. Sometimes they're referred to as canaries in the coal mine. There's about seven or eight in IDEX that are very close to consumption, and they're very fragmented. And so when you see them tracked together in any direction, it tells you something. And so, you know, through the last three years, they've been kind of a mixed bag as the PMI reads have been underneath 50. I'd say in this back half of this year, they've started to move in the direction you would expect when things are broadening and you've got some improvements. So kind of secular drivers first. A couple of sectors, fatigue coming off the mat second, and now some of the things we really like to see, which is just small order rates, day-to-day, variety of businesses tracking together.

Jeff Reeve, Analyst — RBC Capital Markets

Yeah, I want to jump to that industrial stuff next, but just one more on HST before we move on. Does the increasing contribution from Semiconductor introduce more cyclicality in that business, or does the growing consumables for your business kind of help offset that?

Eric D. Ashleman, CEO

Well, I'd say semiconductor always has an element of cyclicality, no matter what everybody says about the current phase that we're in. It's just the nature of how capital is deployed in massive chunks. I would say we've long considered that, which is why we have kind of a cap in mind in the company. We're only going to work on the hardest stuff, the best stuff, the stuff that might grow through some of those cyclical turns just because of its innovative power. That's one. And number two, you know, it's one piece out of many that we have here in the company. So I think just keeping it at a relative. Lower position and making sure it doesn't raise too high is one of the ways that we kind of work the equation overall, especially at the IDEX level.

Jeff Reeve, Analyst — RBC Capital Markets

Got it. And you touched on this briefly, but I know you track day rates across your replenishment type businesses fairly rigorously. Just what are the day rates collectively telling you about the health of the broader industrial landscape and what is that, any view for kind of that?

Eric D. Ashleman, CEO

Yeah, they're not, by no means are they like jumping off the charts and we're reaching new highs or anything, But they are moving in a positive direction, and they move together. We get a report on them every Monday, and it essentially says, here's what came in, Monday, Tuesday, Wednesday, Thursday, Friday of the week before. And because they're different enough, again, you just visually look at it, and we've got some indicators on there. Are they moving in the same direction? So business in Bandit, which makes banding clamps that go in a bunch of industrial applications, is that moving in the same direction as a compressor business selling for pond duration and things like that? Basically, they're channel-intensive businesses, too, so they're going through a lot of fragmented distribution, so it kind of gives you a call there. Then as soon as we start to see that, we go talk to people. So there's, you know, certainly I've been here long enough. I've got relationships with small business owners and dealers and things like that. The ones I view as very credible, I call them up. What are you thinking about? How much risk are you willing to take on? Are you happy or are you sad? We put that next to the data, and that helps us call an inflection. Today, again, I would put it as positive, directional, moving in the same direction, giving us better numbers. We can see it in our order rates that we talked about in Q3. And frankly, doing all of it in the face of some macroeconomic variables that are still pretty negative. High interest rates, inflation, we haven't solved that yet, geopolitical stuff, political uncertainty. Those things normally are inhibiting, maybe inhibiting what we have here, but it's, I think, great to see the lift in the face of that.

Jeff Reeve, Analyst — RBC Capital Markets

Yeah. Are you seeing any divergence in day rates in different end markets or geographies, or is it kind of collectively just getting a little better?

Eric D. Ashleman, CEO

If there was divergence, there'd be enough we wouldn't call this as aligned. So there's always some around the margins, but in general, think of this as, hey, there's enough moving directionally together that we see it as statistically significant.

Jeff Reeve, Analyst — RBC Capital Markets

Are there any other indicators you track to forecast your FMT business?

Eric D. Ashleman, CEO

Again, I think a lot of it is getting, I mean, we're super close to the point of impact here. There's not a bunch of people in between myself and folks making things and selling them and talking to businesses. So we have the privilege of being able to go and talk to them. And I just find the same questions to the same people asked over a number of years gets you answers that you can actually calibrate and hold up to the data. And I just, I hear the same things. I don't think everything is solved for me, but I feel better is usually kind of the beginning of the sentence, and it's because of one of the three things that I mentioned here is a positive impact. It's often followed by, but I would love to see A, B, or C, inflation come down, more sense that we're going to have interest rate relief instead of going the other way, those kind of things. But I think the collective psychology for a lot of the industrial stuff is better than it was at the beginning of the year, certainly better than it was last year.

Jeff Reeve, Analyst — RBC Capital Markets

Super helpful. So we spent a fair amount of time discussing FMT and HST, but I also want to touch on FSDP. So just how are you thinking about the growth outlook across the segment, particularly the opportunities for continued growth in fire and rescue and the potential for recovery and dispensing?

Eric D. Ashleman, CEO

Yeah, I mean, the three businesses we have in that segment are each a little bit more specific. They have their own drivers. Bandit probably feels like an FMT business in many ways. It's clamps that go into a variety of industries, so I kind of put that where I put FMT generally. It does have a very nice extension that's in aerospace and defense. Frankly, it was a big contributor in Q2 order rates for the segment, and now in Q3 and running those parts, and so it's in there on the organic side. So I put Bandit a little bit off to the side. Fire and rescue, you know, we have a number of technologies. We do a bunch of things with, you know, water and the mobility, fire trucks, that side of it. And then we have rescue tools, which are sort of in the same station house, if you will. That business has been driven by and large by North American fire for the last few years. And it's pretty simple. It's two reasons. One, we're well positioned with most of the majors and a lot of the second tier folks as well. They've had a multi, they always had long backlogs. After the pandemic, they got really, really long, because these are kind of custom vehicles and hard to get parts and all of those things. So as those got to a big position, it was in everyone's collective best interest to get more throughput and get that out. As it does, we kind of get that as velocity because of our share position, and it's continued now for quite a while. It's still multi-year in nature. On top of that, we have an automation suite that we put together through Acquired Parts, so we've kind of automated how that work gets done on a firetruck. It helps you take crew size down. I mean, it's truly transformational tech. A lot of that early adoption is embedded in that same backlog I just referred to, so as it comes out, think of it as we almost get two kicks. We get the run out of share position, and then we get the automation loop on top of it, which has been sort of captive. And so there are other things going on in the world, but what has us kind of staying ahead of just, call them pedestrian municipal rates, is the fact that we're disproportionately, we've got this great share position and a backlog, and we've got innovation on top of it. In dispensing, dispensing is by far probably the most cyclical business because a lot of it is driven on the backs of fleet replenishment, especially in North America. As we all know, there's only so many outlets where you get by your paint. We've got great share there, and we know the fleet age, so we're able generally to kind of within a year or two call when the next one's coming. We're still a couple years away from the next fleet replenishment. We've been able to buffer that somewhat over the years through a bunch of growth in emerging markets, specifically in India. So we smoothed out the curve a bit. It was a little noisy in the beginning of the year because we had some crazy comparisons. That's kind of gone away. And so the business is performing exactly as we thought it would, flattish overall, as we expected it might be, but without a bunch of the year-over-year comparison noise.

Jeff Reeve, Analyst — RBC Capital Markets

So we touched on all the segments and the advantage market opportunities. So just putting it all together, how should investors think about IDEX's sustainable organic growth algorithm over the next, say, three to five years? And how much of an improvement could that represent relative to the company's historical growth profile?

Eric D. Ashleman, CEO

Well, I think this is an important part. So I want to go right back to the beginning with my evolutionary story. If you were to really make it oversimplified, essentially, we were a great company with kind of an industrial baseline. So if you were going to take the fulcrum point for organic growth, you generally take the pulse of industrial businesses. We might punch above it 100 or 200 basis points, and then we flow through like crazy as that moves. Essentially, what we've done here by turbocharging, if you will, HST through acquisition and presence in markets like this, is we've now taken an HST segment. We've got that built for kind of high single digits. If the rest of IDEX overall oversimplified as sort of an industrial baseline plus a couple hundred basis points, on average, if you put the two together, your fulcrum point is moved from kind of an industrial line to something mid-single digit plus. That's kind of where we are now. And we've not really changed any of the flow-through characteristics. So if you go back to the beginning, we were getting a lot of our margin expansion through internal optimization up to a natural cap. We're now getting it by moving that fulcrum point, 300 or 400 basis points, to the right with the same identical flow-through characteristics, margin performance, capital intensity. And now, because so much of it is coming on the backs of growth, it's unbounded over time if we do continue to do our job right.

Jeff Reeve, Analyst — RBC Capital Markets

So how should investors think about the incremental flow-through margins, kind of what's your year-over-year kind of expansion target?

Sean M. Gillen, CFO

Yeah. You know, for the company, it's about kind of high 30% is the right flow-through when we're seeing volume in FMT and FSDP. So the HST segments so far this year on significant volume growth has been flowing through in kind of that mid-to-high 30s, which is probably the right place for them to be over time. And then FMT and FSDP, particularly in the second half of this year, and FMT in particular, where we're seeing that volume growth after not seeing volume growth in FMT for a few years, we're starting to see that. Over time, FMT, you know, can be a 40% plus type flow through business. We're kind of calibrating people to higher 30s, you know, high 30s, close to 40, just because allowing some room for investment in the FMT businesses. And then FSDP is somewhere in between. So for overall, as a company, that kind of mid to high 30% flow through is the right place to be. And what does that mean for your EPS growth algorithm? Is that double digits? Where do you target? Well, you start to get, if you do the math on what we've laid out, kind of Eric at the top line talking about mid single digit plus on organic growth. And when you have flow through in the mid to high 30s, you know, all the other variables equal, you start to get into the double digits from an EPS growth standpoint. And that's with, you know, capital allocation, supporting it either on share repurchase, you know, kind of bringing down the denominator. And then, I mean, that's all organic. And then, but a piece of our strategy and capital allocation over time is inorganic. So I would think about the ability to, you know, from there, you increase on an inorganic basis for a total blended growth rate over a cycle.

Jeff Reeve, Analyst — RBC Capital Markets

Right. Maybe sticking with capital allocation. So the third pillar of phase three is balanced returns-focused capital deployment. So when you think about the opportunities to invest organically in these advantaged markets versus pursuing acquisitions, how has the phase three strategy changed the way you evaluate where to deploy capital?

Eric D. Ashleman, CEO

A lot of it does come down to where we want to flex in organically. Number one, we're always going to support the organic efforts of the business, but as we've talked about all along, we honestly don't have that. Many requirements on the CapEx side. It's just not the nature of kind of the work we do the way we do it. And we kind of get to a natural bandwidth. There's only so much capacity to absorb even more CapEx. So that number is easily fundable, and you're kind of moving to the next phase pretty quick, the next tranche. Inorganic, I mean, you know, we talked about a particular burst of energy here that built a lot of the businesses that are here. I think we're in a state now that's more typical for us, that now that this exists, and think of it as like a lattice work, there's a number of attachment points which are here. There's more than ever before. And so as we're engaging with these customers and other folks that are supplying into the industry, some of whom might be candidates, good candidates for acquisition, a lot of the work is being done in the exact same areas. Now, as we think about future M&A.

Jeff Reeve, Analyst — RBC Capital Markets

So are you increasingly prioritizing acquisitions that bring technologies that you can leverage across multiple businesses?

Eric D. Ashleman, CEO

Well, in particular, building depth around the spaces that we've spent a lot of time on here today. There's more work to be done. And I think getting the initial specification points for work of this type, I mean, of all the economic returns that somebody interested in IDECK should be thinking about when we land something like this. You know, it's interesting in the first couple of years and paying off the acquisition and beating our whack, and that's all there. But the real economics come in years 5 through 10, 10 through 20, 20 through 30, where that same, you know, essential position has now been moved to the next level, doesn't take a lot of capital to get it there. The returns start to really flex once you sort of demonstrated this. So a lot of these worlds I just saw as a place where we have to get in there, define how optical stuff is done up in space, define how lithography, heat management is going to happen, because we know if we do it, it's going to tend to iterate and morph over time, and that beachhead is going to stay there and perform really, really well for us.

Jeff Reeve, Analyst — RBC Capital Markets

All right, Eric, maybe one final question to wrap things up. So we spent a lot of time today discussing IDEX's evolution into phase three and the opportunities ahead. As you look out over the next three to five years, what are the one or two things you're most focused on getting right to make phase three a success? Yes.

Eric D. Ashleman, CEO

Well, I think continuing to land the positions that I've just described here, getting even more depth in the markets that we have, what excites me is if you were to put this on a grid, essentially, you'd see three capabilities that we have in IDEX we do really, really well. We play with fluidics. We play with light and optics. And essentially, we play with gas overall. And then you kind of look at these markets and say, if I was to put life science and health up here on the grid, you've kind of got a three by five. So you have 15 points of intersection. When you dig into any one of these intersection points, there's actually a lot more work going on than you would actually realize, more than I thought, even initially. Space and defense is a good example. We never were thought of as a defense company. We never would have talked about it in a forum like this. The only reason we are here is because a lot of the imaging technology that we have in space is actually naturally rolling over into asymmetrical defense threats and the technologies that are going to combat those. It's a really disruptive world. The players there are not your typical prime folks who move kind of at a snail's pace, but people that are thinking disruptively. And we find that it turns out this ability to see things and shoot lasers a long way into space, it's actually required in that world, and so it becomes an adjacency to itself. It's like a door opens, and we are able to go through it, and much of that world is pretty familiar to us. And I think in that three-by-five grid, we see an awful lot of this right now that fits the kind of businesses we do, the economics we like, and our people are really good at it.

Jeff Reeve, Analyst — RBC Capital Markets

So what should investors be watching to gauge whether you're making progress?

Eric D. Ashleman, CEO

Well, I think continued growth, order growth, and then followed by sales growth in the HST segment in the areas that we're describing here. As we do that, we'll talk about new technologies and new installations and new things we brought on board, continuing acquisitive work to support it, I think will be something that you'll see over time. I do think sometimes underappreciated, maybe because of the last few years here, but the economic power of our F&T franchise, when it is moving volume and flexing close to 40% and doing it all with almost no need for capital and cash, that combined with what's going on in the HST side, those two things coming together is really, really powerful. And we really haven't had them yet performing in that way. It's taken us a while to build this, and we've done it in a world where that industrial entitlement has really not moved in the way it should. When the two move together, I think you're going to really like it.

Jeff Reeve, Analyst — RBC Capital Markets

Eric, Sean, I think that's a great place to leave it. Thank you both for joining us today and sharing your perspectives.

Eric D. Ashleman, CEO

Thank you. I appreciate it.

Jeff Reeve, Analyst — RBC Capital Markets

Thanks.